CareDx (CDNA) Gains from Sales and Divestitures (2016 - 2019)

CareDx (CDNA) posted Gains from Sales and Divestitures of $439704.0 for Q2 2019, up 58.76% sequentially from $276954.0 in Q1 2019.

CareDx (CDNA) Gains from Sales and Divestitures (2016 - 2019) Analysis & Trends

CareDx (CDNA) has 3 years of Gains from Sales and Divestitures data on file, last reported at $439704.0 in Q2 2019.

Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $439704.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $439704.0 (changed N/A YoY) and the FY2018 annual result came in at $272806.0, changed N/A from the prior year.
Gains from Sales and Divestitures grew to $439704.0 in Q2 2019 per CDNA's latest filing, from $276954.0 in the prior quarter.
The five-year high for Gains from Sales and Divestitures was $439704.0 in Q2 2019, with the low at $26550.0 in Q1 2016.
Average Gains from Sales and Divestitures over 3 years is $208512.8, with a median of $272806.0 recorded in 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	CareDx	1.50 Bn	1.31 Bn	87.33 Mn

Download Data